医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Recruitment of Purchase Participants for Korean Medical Device Manufacturer SDE

2015年12月14日 PM04:36
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Located in Seongdong-gu, Seoul, Korea, the cosmetic surgery medical device manufacturer SDE Corp. officially announced their plans for technology transfer to overseas markets and for selling of the company.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151213005069/en/

SDE Corp. was established in 2014 as a venture company that manufactures and sells absorbable thread (PDO lifting thread), non-absorbable thread (PP lifting thread) and others, which are medical device consumables referred to as ‘medical sutures’.

Distinct brands of SDE Corp. include EVERKO, EASYKO, and EASY-UP. The company possesses more than four patents in Korea and China, KFDA approval, GMP certification, venture company certification, more than four cosmetic surgery patents, as well as more than four trademark registrations.

EVERKO and EASYKO enjoy very high popularity in the Korean market, and have excellent brand awareness. EASY-UP, which is another one of the brands, is an ergonomic cosmetic aid device. It is inserted into the nose and plays the role of a splint after non-incisional rhinotomy, which includes the rhinoplasty, nose filler, EVERKO, EASYKO, MISSKO, HIGHKO, etc.

According to SDE Corp. a single cosmetic surgery office located in Gangnam, Korea, purchases 10 million won worth of materials each month, and over 100 million won worth of materials a year. They also possess many customer accounts, including over 50 within Korea, in addition to medical institutions and medical device import companies overseas.

SDE Corp. has also noted, “we have determined that the cosmetic surgery market of China and South-East Asia regions, which are experiencing a wave of petite cosmetic surgery, and non-incisional cosmetic surgery, possess a wider consumer base with higher profitability than that of Korea, which has already reached saturation. Also considering only the cosmetic surgery offices and beauty shops located in each of the provinces of China, we predict over 5 billion won worth of earnings each year”. Additionally, the company indicated “Thus, for a better future and for the advancement of cosmetic surgery technology, we have decided to transfer technology overseas and to sell the company.”

Individuals of Chinese nationality or companies interested in this technology transfer and sale of the company may send an email to (sdemedi@naver.com).

View source version on businesswire.com: http://www.businesswire.com/news/home/20151213005069/en/

CONTACT

SDE Corp.
Park, so min, +82-2-547-1184
International
Marketing Manager
sdemedi@naver.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三井化学开发全球首款灵活的高强度柔性无纺布AIRYFA™
  • APR应用制药研究公司参加第9届ChinaBio®合作论坛:依托瑞士创新产品和科学技术深耕中国市场
  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定